MT2013-31:Allo BMT for Metabolic Disorders, Osteopetrosis and Males With Rett Syndrome

Conditions:   Mucopolysaccharidosis Disorders;   Glycoprotein Metabolic Disorders;   Peroxisomal Disorders;   Severe Osteopetrosis;   Rett Syndrome;   SphingolipidosesInterventions:   Biological: rabbit anti-thymocyte globulin;   Drug: Fludarabine monophosphate;   Drug: Busulfan;   Drug: Cyclosporine A;   Drug: Methylprednisolone;   Drug: Mycophenylate Mofetil;   Drug: Granulocyte-Colony Stimulating Factor;   Procedure: bone marrow or peripheral blood stem cell (PBSC) transplantSponsor:   Masonic Cancer Center, University of MinnesotaNot yet recruiting - verified June 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials